Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

Submitted: 6 August 2012
Accepted: 13 February 2013
Published: 28 March 2013
Abstract Views: 2157
PDF: 635
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The spondyloarthritis (SpA) complex includes ankylosing spondylitis (AS), reactive arthritis, psoriatic arthritis, arthritis related to inflammatory bowel disease and forms that do not meet established criteria for these definite categories which are designated as undifferentiated SpA. In the early 1990s, two sets of classification criteria were suggested with the purpose to cover the whole clinical spectrum of SpA: the Amor criteria and the European Spondylarthropathy Study Group (ESSG) criteria...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Olivieri, I., D’Angelo, S., Palazzi, C., Leccese, P., Nigro, A., & Padula, A. (2013). Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis. Reumatismo, 65(1), 1–3. https://doi.org/10.4081/reumatismo.2013.1